Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7018 USD | +0.09% | -0.62% | -76.05% |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Mar. 14 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 4.6M | Sales 2025 * | 1.3M | Capitalization | 28.88M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -60M | EV / Sales 2024 * | -3.31 x |
Net cash position 2024 * | 44.1M | Net cash position 2025 * | 89.5M | EV / Sales 2025 * | -46.6 x |
P/E ratio 2024 * |
-0.6
x | P/E ratio 2025 * |
-0.7
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.37% |
Latest transcript on Spruce Biosciences, Inc.
1 day | +0.09% | ||
1 week | -0.62% | ||
Current month | -10.70% | ||
1 month | -3.86% | ||
3 months | -72.69% | ||
6 months | -38.17% | ||
Current year | -76.05% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 22-01-02 | |
Samir Gharib
DFI | Director of Finance/CFO | 41 | 20-04-30 |
Michael Grey
CHM | Chairman | 71 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Spiegelman
BRD | Director/Board Member | 65 | 20-09-08 |
Michael Grey
CHM | Chairman | 71 | 17-03-31 |
Tiba Aynechi
BRD | Director/Board Member | 48 | 16-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.7018 | +0.09% | 450,764 |
24-04-23 | 0.7012 | +1.33% | 1,030,251 |
24-04-22 | 0.692 | -1.20% | 458,952 |
24-04-19 | 0.7004 | -0.09% | 663,290 |
24-04-18 | 0.701 | -0.74% | 311,619 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-76.05% | 28.88M | |
+4.09% | 43.84B | |
+46.96% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- SPRB Stock